Found 43 matching trials
Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans PHASE2 The purpose of this study is to demonstrate the safety and efficacy of Siro...
Show More Location
New York Harbor VA Brooklyn Campus
Learn More & Join Trial
Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome PHASE2 Sturge-Weber syndrome (SWS) is a rare congenital neuro-cutaneous disorder c...
Show More Location
Clinica Universidad de Navarra
Learn More & Join Trial
Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers PHASE1 This is a phase 1 study in healthy adult volunteers to examine the effects ...
Show More Location
Stanford Dermatology
Learn More & Join Trial
Topical Rapamycin for Fibrofolliculomas PHASE3 The purpose of the study is to determine whether topical application of rap...
Show More Location
VU Medical Centre Amsterdam
Learn More & Join Trial
Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease PHASE1 A recombinant AAV vector has been generated to carry the codon-optimized ac...
Show More Location
Clinical and Translational Research Building (CTRB), University of Florida
Learn More & Join Trial
Everolimus in Treating Cutaneous T-cell Lymphoma PHASE2 CTCL is a rare form of lymphoma of the skin. While early stages are usually...
Show More Location
Boston Medical Center
Learn More & Join Trial
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations PHASE2 A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of ...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Orange County
Learn More & Join Trial
Daily Topical Rapamycin for Vitiligo PHASE2 In current Dermatology practice, options for vitiligo remain limited. The p...
Show More Status
Active Not Recruiting
Location
Medical University of South Carolina
Learn More & Join Trial
Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) PHASE3 The purpose of this trial is to evaluate the efficacy and safety of NPC-12G...
Show More Location
Graduate School of Medicine, Osaka University
Learn More & Join Trial
Topical TOR-582 Treatment of Epistaxis in HHT PHASE1 People with hereditary hemorrhagic telangiectasia (HHT) often experience fr...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial